EMA Authorised: Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva (efavirenz;emtricitabine;tenofovir disoproxil phosphate) — Zentiva k.s.

View source ↗

Summary

The EMA has authorised a fixed-dose combination antiretroviral therapy (efavirenz/emtricitabine/tenofovir disoproxil phosphate) by Zentiva for HIV infections. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Efavirenz/Emtricitabine/Tenofovir disoproxil phosphate Zentiva (efavirenz; emtricitabine; tenofovir disoproxil phosphate)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Zentiva k.s.. Decision date: 18/03/2025